IL-1β and PGE2 levels are increased in the saliva of children with Langerhans cell histiocytosis

被引:6
|
作者
Preliasco, Virginia F. [2 ,3 ]
Benchuya, Carolina [2 ,3 ]
Pavan, Veronica [2 ,3 ]
de la Cal, Carolina [2 ,3 ]
Ganzinelli, Sabrina [1 ,2 ]
Sterin-Borda, Leonor [1 ,2 ]
机构
[1] Univ Buenos Aires, Pharmacol Unit, Sch Dent, Buenos Aires, DF, Argentina
[2] Consejo Nacl Invest Cient & Tecn, Argentine Natl Res Council, RA-1033 Buenos Aires, DF, Argentina
[3] Univ Buenos Aires, Dept Oral Pediat, Sch Dent, Buenos Aires, DF, Argentina
关键词
histiocytosis; interleukin-1; Langerhans cells; oral lesions; prostaglandin E2; saliva;
D O I
10.1111/j.1600-0714.2008.00675.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Langerhans cell histiocytosis (LCH) is a rare disorder mainly of children, whose pathogenesis is still unknown. Some studies have demonstrated that LCH lesions produce different cytokines abnormally that may be relevant to the pathogenesis of the disease. The purpose of this study was to investigate interleukin-1 beta (IL-1 beta) and prostaglandin E2 (PGE(2)) levels in saliva from children with different clinical subtypes of LCH. We studied 29 children with LCH: seven unifocal (Group I), seven multifocal (Group II), 15 multisystemic (Group III) and 12 healthy volunteers (Group IV). Salivary IL-1 beta and PGE(2) levels were significantly higher in LCH than in normal children. A multi-comparison test showed significantly (P < 0.001) higher levels of both IL-1 beta and PGE(2) in saliva from Group III compared with Groups II and I. A significant correlation (r = 0.05) between IL-1 beta and PGE(2) concentrations in saliva from each group was determined. Our findings demonstrated an association between high concentrations of salivary IL-1 beta and PGE(2) and advanced stages of the disease. This allows us to suggest that the abnormal amount of these factors in saliva may serve as a risk marker for disease progression.
引用
收藏
页码:522 / 527
页数:6
相关论文
共 50 条
  • [21] Salivary IL-1β and PGE2 as biomarkers of periodontal status, before and after periodontal treatment
    Sanchez, Gabriel A.
    Miozza, Valeria A.
    Delgado, Alejandra
    Busch, Lucila
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2013, 40 (12) : 1112 - 1117
  • [22] IL-1 INDUCED NITRIC-OXIDE INHIBITS CHONDROCYTE PROLIFERATION VIA PGE2
    BLANCO, F
    LOTZ, M
    FASEB JOURNAL, 1994, 8 (04): : A365 - A365
  • [23] REGULATION BY ONCOSTATIN-M (OM), IL-1 AND PGE2 OF FIBROBLAST CYTOKINE RELEASE
    RICHARDS, CD
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A214 - A214
  • [24] Tyrosine kinase regulates IL-1β-induced PGE2 production in human gingival fibroblasts
    Nakao, S
    Ogata, Y
    Furuyama, S
    Sugiya, H
    JOURNAL OF DENTAL RESEARCH, 1998, 77 : 866 - 866
  • [25] α-MSH and γ-MSH modulate early release of hypothalamic PGE2 and NO induced by IL-1β differently
    Cragnolini, Andrea Beatriz
    Caruso, Carla
    Lasaga, Mercedes
    Scimonelli, Teresa Nieves
    NEUROSCIENCE LETTERS, 2006, 409 (03) : 168 - 172
  • [26] The IL-1 beta PGE2 signalling pathway in human articular cartilage: Repair response?
    MacFarland, AK
    Johnstone, AJ
    Ewen, SWB
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 457 - 457
  • [27] Crevicular IL-1β and PGE2 response in HIV-associated periodontal diseases.
    Shugars, DC
    Chandler, CW
    Patton, LL
    McKaig, RG
    JOURNAL OF DENTAL RESEARCH, 2000, 79 : 313 - 313
  • [28] IL-1β alters fibroblast proliferation through PGE2 via EP3
    White, K.
    Ding, Q.
    Peters-Golden, M.
    Moore, B.
    Ware, L.
    Matthay, M. A.
    Olman, M. A.
    MATRIX BIOLOGY, 2006, 25 : S36 - S36
  • [29] Bromelain Treatment Leads to Maturation of Monocyte-derived Dendritic Cells but Cannot Replace PGE2 in a Cocktail of IL-1β, IL-6, TNF-α and PGE2
    Karlsen, M.
    Hovden, A. -O.
    Vogelsang, P.
    Tysnes, B. B.
    Appel, S.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2011, 74 (02) : 135 - 143
  • [30] Human dermal papilla cells express IL-1 beta and IL-1RA: Regulation by cytokines and PGE2
    Stracke, H
    Konig, A
    Happle, R
    Hoffmann, R
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (04) : 821 - 821